Immunai

We partner with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics

Immunai maps the immune system at large scale and resolution to help biopharmaceutical companies and research institutions develop immune-related therapeutics. It works as a partner rather than a self-serve tool: the site describes collaborations with AstraZeneca on IBD target discovery and with Teva on vitiligo disease mechanisms and biomarkers for an IL-15 targeted antibody.

Its platform turns complex therapeutic questions into recommendations across an end-to-end drug development workflow, with three named solutions. Target Discovery identifies high-impact targets linked to disease, Preclinical Evaluation prioritizes the most promising drug candidates, and Clinical Trial Optimization helps teams better understand a drug's mechanism of action. Filed under Research in this directory, Immunai is aimed at pharma decision-makers who need to reduce risk and move faster through development.

No pricing is published; engagement starts by contacting the company, so expect an enterprise partnership rather than a subscription. Research groups and pharma teams can reach out through the Partner with us link on the site.

Category: Research. Pricing: enterprise. Visit website

Alternatives to Immunai in Research

• Yila AI — Evidence-traceable research agent for literature review, PDF analysis, figures, and academic slides.
• Deep Search — AI web research, chat and public-information lookups
• ScholarIQ — ScholarIQ searches 470M+ articles from OpenAlex, ORCID and PubMed — and answers in plain language, with every claim cit…
• Tracetify — Evidence-led competitor launch intelligence for founders and marketers.
• XLeadForge — X outbound, queued daily in your voice
• Reverse Image Location — AI image geolocation and visual clue analysis